Raymond James & Associates’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$785K Buy
3,720
+1,123
+43% +$195K ﹤0.01% 2839
2024
Q2
$348K Buy
2,597
+1,494
+135% +$283K ﹤0.01% 3282
2024
Q1
$237K Buy
+1,103
New +$216K ﹤0.01% 3523
2023
Q4
Sell
-5,767
Closed -$1.14M 3885
2023
Q3
$1.14M Buy
5,767
+564
+11% +$142K ﹤0.01% 2372
2023
Q2
$1.69M Sell
5,203
-10,135
-66% -$2.9M ﹤0.01% 2169
2023
Q1
$3.59M Buy
15,338
+648
+4% +$164K ﹤0.01% 1693
2022
Q4
$3.7M Sell
14,690
-221
-1% -$47.1K ﹤0.01% 1623
2022
Q3
$2.65M Buy
14,911
+593
+4% +$119K ﹤0.01% 1792
2022
Q2
$2.62M Buy
14,318
+4,234
+42% +$844K ﹤0.01% 1827
2022
Q1
$2.59M Sell
10,084
-1,093
-10% -$250K ﹤0.01% 1951
2021
Q4
$2.57M Buy
11,177
+968
+9% +$236K ﹤0.01% 1992
2021
Q3
$2.38M Sell
10,209
-959
-9% -$200K ﹤0.01% 1980
2021
Q2
$2.16M Sell
11,168
-1,655
-13% -$328K ﹤0.01% 2045
2021
Q1
$2.65M Buy
12,823
+432
+3% +$91.8K ﹤0.01% 1824
2020
Q4
$2.33M Buy
12,391
+222
+2% +$36.3K ﹤0.01% 1803
2020
Q3
$1.57M Sell
12,169
-791
-6% -$87.2K ﹤0.01% 1907
2020
Q2
$1.13M Buy
12,960
+5,697
+78% +$438K ﹤0.01% 2082
2020
Q1
$438K Buy
+7,263
New +$537K ﹤0.01% 2502

Other funds holding INSP

Raymond James & Associates's INSP Position: Q3 2024 in Review

Raymond James & Associates increased its Inspire Medical Systems (INSP) stake by 43% in Q3 2024, buying an estimated $195K and bringing the position to 3,720 shares worth $785K. The position accounts for ﹤0.01% of the portfolio, ranked #2839.

Raymond James & Associates first reported a position in INSP in Q1 2020 and has held it in 18 quarters since. The position peaked at $3.7M in Q4 2022. 346 funds tracked by Wall St. Rank hold INSP as of Q3 2024.

  • Raymond James & Associates held 3,720 shares of Inspire Medical Systems worth $785K as of Q3 2024.
  • Raymond James & Associates bought 1,123 Inspire Medical Systems shares in Q3 2024, an estimated $195K.
  • Inspire Medical Systems made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2839 holding.
  • Raymond James & Associates first reported a position in Inspire Medical Systems in Q1 2020 and has held it in 18 quarters since.
  • Raymond James & Associates's Inspire Medical Systems position peaked at $3.7M in Q4 2022.
  • 346 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.